Christopher Hocking

1.1k citations
16 papers · 334 · 1 hit paper · h-index 8

Impact in

    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Colorectal Cancer Treatments and Studies 8
    • Cancer Immunotherapy and Biomarkers 2
    • Colorectal Cancer Surgical Treatments 2
    • Renal cell carcinoma treatment 3
    • Gastric Cancer Management and Outcomes 3

Christopher Hocking

16 papers receiving 329 citations

Christopher Hocking's Hit Papers

Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial 2022 · 177 citations
1770+1+2Years since publication50100150

Peers

Christopher Hocking
Comparison fields: 5 of 52
  • Oncology 173
  • Cancer Research 86
  • Pulmonary and Respiratory Medicine 186
  • Hepatology 18
  • Surgery 85
Replace Phani Keerthi Surapaneni with:
Phani Keerthi Surapaneni United States
Yuming Rong China
Tadashi Uwagawa Japan
Noriaki Tokumoto Japan
Masato Kataoka Japan
Dong Peng China
Dimitrios Korkolis Greece
Abdullah Sakin Türkiye
Baran Akagündüz Türkiye
Christopher Hocking relative to Phani Keerthi Surapaneni United States Phani Keerthi Surapaneni's profile →
Citations per field
00.5×2.6×
Phani Keerthi Surapaneni · 1×
Citations per year

Countries citing papers authored by Christopher Hocking

Since Specialization
Citations

This map shows the geographic impact of Christopher Hocking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Hocking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Hocking more than expected).

Fields of papers citing papers by Christopher Hocking

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Hocking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Hocking. The network helps show where Christopher Hocking may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Hocking, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Hocking Line = papers co-authored together Christopher Hocking links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
Hit paper breakdown →
2022177
2 201455
3 201328
4 201319
5 202216
6 20149
7 20149
8 20138
9 20133
10 20153
11 20222
12 20241
13 20241
14 20141
15 20141
16 20211

About Christopher Hocking

Christopher Hocking is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and General Health Professions, having authored 16 papers that have together received 334 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Renal cell carcinoma treatment (3 papers), Gastric Cancer Management and Outcomes (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Genetic factors in colorectal cancer (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). The work is most often cited by research in Oncology (173 citations), Cancer Research (86 citations), Pulmonary and Respiratory Medicine (186 citations), Hepatology (18 citations) and Surgery (85 citations). Christopher Hocking has collaborated with scholars based in Australia, United Kingdom and Japan. Frequent co-authors include Ganessan Kichenadasse, Timothy Price, María T. Bourlon, Joshua Zhang, Christian Scheffold, Burçin Şimşek, Camillo Porta, Thomas Powles, Bernard Escudier and Toni K. Choueiri. Their work appears in journals such as Journal of Clinical Oncology, The Medical Journal of Australia, BMJ Open, The Journal of Urology and Australian Journal of Rural Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact